Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Exact Sciences Cor (EXAS)

Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 20,026,062
  • Shares Outstanding, K 190,888
  • Annual Sales, $ 3,247 M
  • Annual Income, $ -207,950 K
  • EBIT $ -206 M
  • EBITDA $ 22 M
  • 60-Month Beta 1.41
  • Price/Sales 6.11
  • Price/Cash Flow 82.83
  • Price/Book 8.34
  • Price/Earnings ttm 2,598.00
  • Earnings Per Share ttm 0.04
  • Most Recent Earnings $-0.21 on 02/13/26
  • Next Earnings Date 05/07/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 20 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 0.05
  • Number of Estimates 1
  • High Estimate 0.05
  • Low Estimate 0.05
  • Prior Year -0.21
  • Growth Rate Est. (year over year) +123.81%

Price Performance

See More
Period Period Low Period High Performance
1-Month
102.95 +1.90%
on 02/27/26
104.98 -0.07%
on 03/20/26
+1.48 (+1.43%)
since 02/20/26
3-Month
101.44 +3.42%
on 12/23/25
104.98 -0.07%
on 03/20/26
+3.09 (+3.03%)
since 12/19/25
52-Week
38.81 +170.30%
on 08/07/25
104.98 -0.07%
on 03/20/26
+60.63 (+136.92%)
since 03/20/25

Most Recent Stories

More News
How Is Quest Diagnostics’ Stock Performance Compared to Other Healthcare Stocks?

Quest Diagnostics has outpaced its healthcare peers over the past year, and analysts are maintaining a moderately positive outlook on its future performance.

XLV : 143.26 (-1.70%)
DGX : 195.51 (-1.33%)
EXAS : 104.91 (+0.95%)
Exact Sciences to Present New Molecular Residual Disease and Multi-Cancer Early Detection Data at AACR 2026

The Oncodetect ® test expands the role of tumor-informed MRD in triple-negative breast cancer The Cancerguard ® test demonstrates improved...

EXAS : 104.91 (+0.95%)
1 Mid-Cap Stock to Consider Right Now and 2 Facing Headwinds

1 Mid-Cap Stock to Consider Right Now and 2 Facing Headwinds

HRL : 23.07 (+0.96%)
EXAS : 104.91 (+0.95%)
CACI : 563.67 (-2.79%)
3 Cash-Producing Stocks We Approach with Caution

3 Cash-Producing Stocks We Approach with Caution

EXAS : 104.91 (+0.95%)
PEN : 335.10 (-0.39%)
HRB : 31.21 (-0.22%)
Exact Sciences Named Gallup Exceptional Workplace Award Winner for Third Consecutive Year

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced it has earned the 2026 Gallup Exceptional Workplace Award (GEWA), marking the third consecutive...

EXAS : 104.91 (+0.95%)
Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration

Amalgam Rx, Inc., Privia Health, and Exact Sciences Corp. highlight how coordinated, EHR-enabled patient outreach supported measurable screening impact at scale.

EXAS : 104.91 (+0.95%)
PRVA : 20.02 (-0.79%)
Exact Sciences Stockholders Approve Acquisition by Abbott

Exact Sciences Corporation (NASDAQ: EXAS) (“Exact Sciences”), a leading provider of cancer screening and diagnostic tests, today announced that its stockholders voted to approve the proposed acquisition...

ABT : 103.99 (-0.55%)
EXAS : 104.91 (+0.95%)
Paul Tudor Jones Is Betting Big on Google Stock. Should You?

Paul Tudor has bought a fresh position on tech giant Google and more.

GOOG : 273.76 (-2.49%)
GOOGL : 274.34 (-2.34%)
META : 525.72 (-3.99%)
$SSPL : 3,003.34 (-1.96%)
SEE : 42.00 (unch)
EXAS : 104.91 (+0.95%)
JPM : 282.84 (-3.02%)
IBIT : 37.40 (-3.66%)
IVV : 636.99 (-1.70%)
SPY : 634.09 (-1.71%)
BA : 190.52 (-1.98%)
3 Unpopular Stocks We Approach with Caution

3 Unpopular Stocks We Approach with Caution

VMI : 392.04 (-1.64%)
EXAS : 104.91 (+0.95%)
ALG : 167.00 (-0.94%)
3 Overrated Stocks That Concern Us

3 Overrated Stocks That Concern Us

EXAS : 104.91 (+0.95%)
TPH : 46.69 (+0.04%)
SIGI : 74.68 (-0.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 70%. The market has entered overbought territory.

See More Share

Business Summary

Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of some of the deadliest forms of cancer. The company has developed an accurate, non-invasive, patient-friendly screening test called Cologuard for the early detection of colorectal cancer and...

See More

Key Turning Points

3rd Resistance Point 105.04
2nd Resistance Point 105.01
1st Resistance Point 104.96
Last Price 104.91
1st Support Level 104.88
2nd Support Level 104.85
3rd Support Level 104.80

See More

52-Week High 104.98
Last Price 104.91
Fibonacci 61.8% 79.70
Fibonacci 50% 71.90
Fibonacci 38.2% 64.09
52-Week Low 38.81

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.